David Grainger
Founder at Total Medical Ventures
Net worth: 8 M $ as of 29/04/2024
Network origin in David Grainger first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Cambridge
237
| College/University | Other Consumer Services | 237 |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.
25
| Private Company | Investment Managers | 25 |
| Public Company | Pharmaceuticals: Major | 13 | |
Morphogen-IX Ltd.
 Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom.
9
| Subsidiary | Miscellaneous Commercial Services | 9 |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.
8
| Subsidiary | Biotechnology | 8 |
Epsilon-3 Bio Ltd
 Epsilon-3 Bio Ltd Pharmaceuticals: OtherHealth Technology Epsilon-3 Bio Ltd. develops compounds targeting the removal of cellular debris in chronic inflammatory and autoimmune disorders. The company was founded by Martin W. Edwards, Konstantinos Efthymiopoulos, David J. Grainger and Christian De La Tour on June 18, 2010 and is headquartered in Cambridge, the United Kingdom.
6
| Holding Company | Pharmaceuticals: Other | 6 |
Magdalene College
5
| College/University | Other Consumer Services | 5 |
SDS Therapeutics Ltd.
 SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Total Medical Ventures
 Total Medical Ventures Investment ManagersFinance Total Medical Ventures (Total Medical) is a seed and early stage venture capital firm founded in 2001 by David J. Grainger.
3
| Private Company | Investment Managers | 3 |
Methuselah Health UK Ltd.
 Methuselah Health UK Ltd. BiotechnologyHealth Technology Methuselah Health UK Ltd. develops platforms for the detection of major diseases for middle and old age people. The company was founded by David John Grainger in 2015 and is headquartered in Babraham, the United Kingdom.
3
| Subsidiary | Biotechnology | 3 |
Critical Pressure Ltd.
 Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
RxCelerate Ltd.
 RxCelerate Ltd. BiotechnologyHealth Technology RxCelerate Ltd. provides drug development solutions. It is an out-sourced drug development company, delivering preclinical drug development programmes and project management for virtual and semi-virtual companies. The firm services include routine animal models of human diseases, toxicology and ADME studies. The company was founded by David John Grainger in April 2012 and is headquartered in Cambridge, the United Kingdom.
2
| Holding Company | Biotechnology | 2 |
Inhibitaxin Ltd.
 Inhibitaxin Ltd. BiotechnologyHealth Technology Inhibitaxin Ltd. engages in research and development on biotechnology. The company was founded by Simon Lempriere Westbrook and Kevin S. Johnson in 2013 and is headquartered in Kent, the United Kingodm.
2
| Private Company | Biotechnology | 2 |
Rebalance (Cambridge) Ltd.
 Rebalance (Cambridge) Ltd. Miscellaneous Commercial ServicesCommercial Services Rebalance (Cambridge) Ltd. provides research and experimental development on biotechnology. The company was founded on December 6, 2016 and is headquartered in Hatfield, the United Kingdom.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Total Scientific Ltd.
 Total Scientific Ltd. Miscellaneous Commercial ServicesCommercial Services Total Scientific Ltd. provides biomarker related research and development services. It provides services to the pharmaceutical, diagnostic, and academic communities. The firm operates as a contract research organization. Its services include biomarker discovery and clinical studies, bio analysis, data management and biostatistics, and in vivo pre-clinical services. The company was founded by David J. Grainger and David E. Mosedale in 2006 and is headquartered in Cambridge, the United Kingdom.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Human Antibody Factory Ltd.
 Human Antibody Factory Ltd. BiotechnologyHealth Technology Human Antibody Factory Ltd. provides research and experimental development on biotechnology. The company was founded by David John Grainger and is headquartered in Hatfield, the United Kingdom.
1
| Holding Company | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David Grainger via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Founder Founder | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Founder Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
| University College London | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
| Imperial College London | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| COMPUGEN LTD. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| Singapore Academy of Law | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO | |
Levicept Ltd.
 Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Chairman Director/Board Member Founder | |
| Index Ventures (UK) LLP | Investment Managers | Private Equity Investor Private Equity Investor | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kaerus Bioscience Ltd. | Chairman Director/Board Member | ||
Janpix Holdings, Inc.
 Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Human Resources Officer Private Equity Investor | |
| REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Founder Director/Board Member | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| IPSEN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PCCW LIMITED | Major Telecommunications | Corporate Officer/Principal Corporate Officer/Principal | |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | Biotechnology | Director/Board Member Director/Board Member | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree Undergraduate Degree | |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
| EVERGREEN PRODUCTS GROUP LIMITED | Household/Personal Care | Director/Board Member Director/Board Member | |
Evergreen Products Factory Ltd.
 Evergreen Products Factory Ltd. Industrial ConglomeratesProducer Manufacturing Part of Evergreen Products Group Ltd., Evergreen Products Factory Ltd. is a Chinese company that manufactures and exports wigs and hair pieces. The company is based in Hong Kong, Hong Kong. | Industrial Conglomerates | Director/Board Member Director/Board Member | |
| Seavi Advent Ocean Private Equity Ltd. | Director/Board Member Director/Board Member | ||
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
UltraHuman Ltd.
 UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Media Literacy Council | Chairman Director/Board Member | ||
Singapore International Arbitration Centre
 Singapore International Arbitration Centre Miscellaneous Commercial ServicesCommercial Services The Singapore International Arbitration Centre (SIAC) is an independent, not-for-profit organization that provides arbitration services to the business community. The SIAC is based in Singapore, Singapore. The organization administers arbitration in accordance with the arbitration rules of the Singapore International Arbitration Centre for the time being. Since its establishment in 1991, SIAC has gained a reputation for offering best-in-class arbitration services. The SIAC arbitration awards have been enforced in many jurisdictions worldwide. SIAC also offers investment arbitration rules and UNCITRAL rules. Additionally, SIAC has a young SIAC group (YSIAC) that aims to promote the use of international arbitration and other forms of alternative dispute resolution, both regionally and internationally. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
TSMP Law Corp.
 TSMP Law Corp. Miscellaneous Commercial ServicesCommercial Services TSMP Law Corp. is a pre-eminent, independent law firm that provides top quality advice on corporate and commercial law. The private company is based in Singapore, Singapore. The Singaporean company caters to a wide range of clients, from blue-chip companies to start-ups, and are a go-to for international firms and clients. Shen Yi Thio has been the CEO of the company since 1998. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer |
Statistics
International
| United States | 18 |
| United Kingdom | 15 |
| Singapore | 6 |
| Netherlands | 4 |
| Switzerland | 3 |
Sectoral
| Health Technology | 30 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 4 |
| Communications | 2 |
Operational
| Director/Board Member | 529 |
| Corporate Officer/Principal | 157 |
| Independent Dir/Board Member | 96 |
| Chairman | 60 |
| Founder | 59 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Johnson Chen | 42 |
| Wai Han Lock | 40 |
| Martin Edwards | 38 |
| Francesco de Rubertis | 36 |
| Michèle Ollier | 33 |
| Cheng Han Tan | 32 |
| Nanna Liebach Lüneborg | 29 |
| Roel Bulthuis | 29 |
| Giuseppe Zocco | 26 |
| Eu Tse Loh | 25 |
| Mohamed Nazir bin Abdul Razak | 25 |
| Michael Gladstone | 23 |
| Georg Müller | 23 |
| Kevin Johnson | 22 |
- Stock Market
- Insiders
- David Grainger
- Company connections
